Daniel Swisher
Chairman presso CERUS CORPORATION
Patrimonio netto: 7 M $ in data 29/02/2024
Profilo
Daniel N. Swisher è presidente e direttore operativo di Jazz Pharmaceuticals Plc, presidente e direttore operativo di Jazz Pharmaceuticals, Inc., direttore indipendente di Corcept Therapeutics, Inc. e presidente di Cerus Corp. Fa parte del Consiglio di amministrazione di Corcept Therapeutics, Inc. Swisher è stato precedentemente impiegato come presidente, amministratore delegato, segretario e direttore di Sunesis Pharmaceuticals, Inc. e vicepresidente senior delle vendite e del marketing di ALZA Corp. Si è laureato alla Yale University e ha conseguito un MBA alla Stanford Graduate School of Business.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
01/05/2023 | 55 014 ( 0.09% ) | 7 M $ | 29/02/2024 | |
CERUS CORPORATION
0.06% | 07/06/2023 | 104 545 ( 0.06% ) | 227 908 $ | 29/02/2024 |
26/10/2023 | 0 ( -.--% ) | - $ | 29/02/2024 | |
01/03/2024 | 0 ( -.--% ) | - $ | 29/02/2024 |
Posizioni attive di Daniel Swisher
Società | Posizione | Inizio |
---|---|---|
CERUS CORPORATION | Chairman | 01/10/2013 |
CORCEPT THERAPEUTICS INCORPORATED | Director/Board Member | 18/06/2015 |
PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 26/10/2023 |
Precedenti posizioni note di Daniel Swisher
Società | Posizione | Fine |
---|---|---|
JAZZ PHARMACEUTICALS PLC | President | 01/10/2023 |
VIRACTA THERAPEUTICS, INC. | Chief Executive Officer | 31/12/2017 |
ALZA CORPORATION | Sales & Marketing | 01/09/2001 |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | President | - |
Formazione di Daniel Swisher
Yale University | Undergraduate Degree |
Stanford Graduate School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
CERUS CORPORATION | Health Technology |
CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
PROTAGONIST THERAPEUTICS, INC. | Health Technology |
JAZZ PHARMACEUTICALS PLC | Health Technology |
Aziende private | 3 |
---|---|
ALZA Corp.
ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |